PO.6.134 Safety and tolerability of nipocalimab administered at different rates of intravenous infusion in healthy adults: a phase 1 placebo-controlled single-dose study

• L Ling,
• A Vermeulen,
• J Leu,
• F Zazzetti

Affiliations

L Ling

1Asian Medical Students Association (Australian Chapter)

A Vermeulen

2Janssen Research and Development, a division of Janssen Pharmaceutica NV ~ Beerse ~ Belgium

J Leu

1Janssen Research and Development, LLC ~ Spring House ~ USA

F Zazzetti

3Janssen Medical Affairs Global Services, LLC ~ Buenos Aires ~ Argentina